Nano-X Imaging Ltd. (NNOX) News
Filter NNOX News Items
NNOX News Results
|Loading, please wait...|
NNOX News Highlights
- For NNOX, its 30 day story count is now at 2.
- Over the past 8 days, the trend for NNOX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest NNOX News From Around the Web
Below are the latest news stories about NANO-X IMAGING LTD that investors may wish to consider to help them evaluate NNOX as an investment opportunity.
NEVE ILAN, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in two investor conferences in the month of September 2022: LifeSci Partners HealthTech Symposium on September 20-21, 2022Ladenburg Thalmann Healthcare Conference on September 29, 2022 About LifeSci Partners HealthTech Symposium Nanox’s Chief Executive Officer, Erez Meltzer, an
Bringing one to market is even harder, as companies must navigate regulatory and commercial landscapes. Nano-X Imaging has learned these lessons the hard way. The Israeli company captured the imaginations of retail investors shortly after debuting on the public market two years ago but has encountered multiple regulatory and manufacturing setbacks.
One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).
Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended June 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process operations, and other matters.
NEVE ILAN, Israel, August 16, 2022--Nanox Announces Second Quarter 2022 Financial Results and Provides Business Update
Every investor in Nano-X Imaging Ltd. ( NASDAQ:NNOX ) should be aware of the most powerful shareholder groups...
Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.
NEVE ILAN, Israel, August 01, 2022--Nanox to Report Second Quarter 2022 Financial Results on August 16, 2022
Contrarian investing is fun because when you nail a contrarian pick correctly, you get the joy of saying "I told you so!" Seeing the value in opportunities that other investors discard means capturing outsized profits when things go right. Nano-X's product in development is the Nanox.ARC, an X-ray imaging device that's significantly less expensive to operate than traditional X-ray machines used in hospitals worldwide thanks to its innovative low-cost X-ray tubes. The idea is that when paired with the company's artificial intelligence (AI) software package, remote clinics in economically disadvantaged areas that might not have enough money for an X-ray machine or a radiologist can use the Nanox.ARC and pay Nano-X for each scan they perform.
Earlier today, NANO-X IMAGING LTD. released financial results for the quarter ended March 31, 2022. Erez Meltzer, chief executive officer, and Ran Daniel, chief financial officer, will host this afternoon's call.